Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
12/2007
12/19/2007EP1497261B1 Phenethanolamine derivatives
12/19/2007EP1115693B9 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
12/13/2007WO2007141423A1 Ppar enhancing derivatives, method for preparing same and therapeutic use thereof
12/13/2007DE19756888B4 Reversibles wärmeempfindliches Aufzeichnungsmaterial, Verfahren zur Herstellung, Aufzeichnungsverfahren und Beschichtungsflüssigkeit A reversible thermosensitive recording material, methods of making, recording method, and the coating liquid
12/12/2007EP1863748A1 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
12/12/2007CN100354259C Substituted tetralins and indanes and their use
12/12/2007CN100354198C Low viscosity copper solvent extraction reagent formulations
12/11/2007US7307078 Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/05/2007EP1861358A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist, and pharmaceutical compositions containing the same
12/05/2007EP1861357A1 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
12/05/2007EP1272458B1 Arginine mimetics as factor xa inhibitors
12/05/2007CN101084251A Radiation-hardenable compounds
12/05/2007CN101081822A Industrial preparation method of halogenated carbonyl aniline
12/04/2007CA2253839C Diformylurea and reaction products of urea and carboxylic acids
11/2007
11/29/2007WO2007137107A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/29/2007WO2007137029A1 Therapeutic fluoroethyl ureas
11/29/2007WO2007134971A1 Benzoyl-substituted alanines
11/29/2007WO2007084882A3 Process for the preparation of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides and intermediates used therein
11/29/2007CA2652117A1 Therapeutic fluoroethyl ureas
11/28/2007CN101080389A Indane amides with antiproliferative activity
11/27/2007CA2379695C Compounds for modulating the rage receptor
11/27/2007CA2299710C Aryloxyaniline derivatives
11/22/2007WO2007131336A1 New materials for lithographic plates coatings, lithographic plates and coatings containing same, methods of preparation and use
11/22/2007US20070270498 Therapeutic fluoroethyl ureas
11/22/2007CA2646739A1 Hydrophilic stain release agents
11/21/2007EP1856037A1 Amidino-compounds for stabilizing factor vii polypeptide formulations
11/20/2007CA2305906C Defoamers for aqueous media
11/15/2007WO2007130898A1 TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007US20070265345 Novel Biphenyl Compounds And Their Use
11/15/2007US20070264262 Adrenoceptor beta 2-mediated diseases such as asthma and chronic obstructive pulmonary disease (COPD); N-(4-tert-butylbenzyl)-4-{[({3-[(2R)-2-(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino)propyl]phenyl}acetyl)amino]methy} benzamide
11/15/2007CA2649677A1 Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
11/14/2007EP1853556A1 Derivatives of aminobutanoic acid inhibiting cpt
11/14/2007CN100348578C Equipment of preparing birueal by using carbamide as raw material
11/08/2007WO2007124898A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR
11/08/2007WO2007107352A8 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
11/08/2007US20070259961 Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal or cancer
11/07/2007EP1851193A1 Hiv protease inhibitors
11/07/2007CN101068791A Method for preparing salt with tetrafluoroborate anion and reducing the content of hologenate
11/07/2007CN100347151C Novel aminobenzoephenones
11/01/2007WO2007122847A1 Reagent for organic synthesis and method of organic synthesis reaction with the reagent
10/2007
10/31/2007EP1246795B1 Antibacterial agents
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007US7288213 (Cyclo)condensing an isocyanate to produce a tricondensate polyfunctional isocyanate reaction product; reacting a linear alkyl isocyanate monomer with C4-C8 linear alkyl alcohol to obtain an allophanate; and mixing the reaction products
10/30/2007CA2172571C Hydroxy-functional prepolymers containing hydantoin group precursors and their use in coating compositions
10/25/2007US20070249821 Small RNA purification
10/25/2007US20070249816 Methods for carbon istope labeling synthesis by rhodium-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007CA2645371A1 Process for the treatment of a product stream
10/24/2007EP1287006B1 Antitumoral compounds
10/23/2007CA2213032C Process for the manufacture of allophanates having isocyanate groups
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/17/2007EP1844767A2 Epoxide hydrolase complexes and methods therewith
10/17/2007EP1844002A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
10/17/2007CN101053558A Diphenylethylene compounds and uses thereof
10/16/2007US7282512 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007EP1154764B1 Use of epoxide hydrolase complexes for treating hypertension
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/04/2007WO2007049158A3 Ppar modulating biaromatic compounds
10/04/2007US20070232485 Low-cure powder coatings and methods for using the same
10/04/2007DE102006014335A1 Verdichtung von Sauerstoff Compression of oxygen
10/02/2007CA2096407C Retroviral protease inhibitors
09/2007
09/27/2007WO2007107352A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
09/27/2007CA2646541A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
09/26/2007EP1836179A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
09/26/2007EP1383750B1 Urea derivatives as integrin alpha 4 antagonists
09/26/2007EP1302461B1 Tnf-alpha production inhibitors
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/25/2007CA2415551C Aniline derivatives
09/20/2007WO2007106525A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
09/20/2007WO2007105793A1 Method for nitrating isourea
09/20/2007WO2007105050A1 Dibenzyl amine compounds and derivatives
09/20/2007CA2646154A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
09/19/2007EP1594836B1 Hydroxy-tetrahydro-naphthalenylurea derivatives
09/19/2007EP1198456B1 Potassium channel openers
09/19/2007CN101037400A Preparation method of L-Ornithine-Malic Acid
09/18/2007USRE39850 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
09/18/2007US7271197 prophylaxis and treatment of respiratory diseases; compounds having potent and selective stimulant action at beta 2-adrenoreceptors and having an advantageous profile of action
09/18/2007CA2416229C Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
09/13/2007WO2007103485A2 Small rna purification
09/13/2007US20070213379 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
09/13/2007US20070213336 peroxisome proliferator activated receptor agonists, such as (E)-3-[3'-(3-heptyl-1-methylureido)biphenyl-4-yl]acrylic acid, useful in human or veterinary medicine (in dermatology, cardiovascular diseases, immune diseases and/or metabolism of lipids); cosmetics
09/13/2007DE102006010721A1 Biuretverbindungen zur Rheologiesteuerung Biuret for rheology
09/12/2007EP1832573A2 Buret connections for rheology control
09/12/2007EP1831279A1 Radiation-hardenable compounds
09/12/2007EP1831179A1 Method for the production of onium salts with tetrafluoroborate anion having a reduced halide content
09/12/2007CN101035758A Phenyl derivatives and methods of use
09/12/2007CN101033204A Biuret compounds for rheology control
09/12/2007CN101033203A Method of preparing 1-(4-chloro-phenyl)-3-(3,4-dichloro-phenyl)-urea
09/12/2007CN100336804C Water phase high pressure method for preparing N,N'-di (m-tolyl) urea
09/12/2007CN100336795C Urea process of synthesizing tert-butyl amine with tert-butyl alcohol
09/11/2007US7268202 Polyisocyanate composition having allophanate group and high-solid coating material
09/11/2007CA2255858C Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
09/11/2007CA2254066C Compounds with anti-inflammatory and immunosuppressive activities
09/11/2007CA2070419C Synthesis and use of amino acid fluorides as peptide coupling reagents
09/08/2007CA2581016A1 Biuret compounds for rheology control
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 99